Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of J2H-1702 in Non-alcoholic Steatohepatitis (NASH)
KCT0007904Phase 2Completed
- Sponsor
- J2H Biotech
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of J2H-1702 in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by J2H Biotech. Started Feb 2023; status: completed.
02
Drugs
J2H-1702
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on KCT0007904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007904.